|
CCNI expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.022400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.564100E-02 |
| Normal-vs-Stage2 |
1.577820E-01 |
| Normal-vs-Stage3 |
2.56539999998751E-06 |
| Normal-vs-Stage4 |
2.13540000015833E-07 |
| Stage1-vs-Stage2 |
2.621700E-02 |
| Stage1-vs-Stage3 |
5.48759999663417E-08 |
| Stage1-vs-Stage4 |
1.20919999568869E-08 |
| Stage2-vs-Stage3 |
8.317600E-02 |
| Stage2-vs-Stage4 |
1.474180E-02 |
| Stage3-vs-Stage4 |
3.564200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.088500E-02 |
| Normal-vs-AfricanAmerican |
1.725820E-02 |
| Normal-vs-Asian |
7.257000E-01 |
| Caucasian-vs-AfricanAmerican |
7.314400E-02 |
| Caucasian-vs-Asian |
9.491000E-01 |
| AfricanAmerican-vs-Asian |
5.749000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.952050E-02 |
| Normal-vs-Female |
2.199200E-01 |
| Male-vs-Female |
5.327000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.993600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.220800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.613700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.418960E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.920400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.066800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.729800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.844800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.501600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.751800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.808770E-01 |
| Normal-vs-Grade 2 |
2.375400E-01 |
| Normal-vs-Grade 3 |
1.895750E-03 |
| Normal-vs-Grade 4 |
4.64369998010028E-09 |
| Grade 1-vs-Grade 2 |
3.522800E-01 |
| Grade 1-vs-Grade 3 |
3.142100E-02 |
| Grade 1-vs-Grade 4 |
1.424780E-04 |
| Grade 2-vs-Grade 3 |
3.168100E-04 |
| Grade 2-vs-Grade 4 |
8.01889998847116E-10 |
| Grade 3-vs-Grade 4 |
7.551400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.393700E-02 |
| Normal-vs-ccB subtype |
5.130100E-02 |
| ccA subtype-vs-ccB subtype |
8.179100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.758000E-02 |
| Normal-vs-N1 |
2.672100E-02 |
| N0-vs-N1 |
4.131500E-02 |
|
|
